-+ 0.00%
-+ 0.00%
-+ 0.00%

*OmniAb: OmniAb, Inc. and ArrowMark Partners Sign License and Services Agreement for Novel OmniAb-Derived Antibody Discovery Programs With Mabtrx Biosciences >OABI

Dow Jones·11/17/2025 22:28:00

Please log in to view news